Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Postnatal Thyroxine Supplementation in Infants Less Than 32 Weeks' Gestation: Effects on Pulmonary Morbidity

Journal of Perinatology volume 20, pages 427–431 (2000)Cite this article

Abstract

OBJECTIVE: Transient hypothyroxinemia in premature newborns has been linked with poor neonatal outcomes. We designed this study to evaluate the effects of early thyroxine (T4) administration in the premature infant.

STUDY DESIGN: A total of 49 newborns less than 32 weeks' gestation, were randomized in a double-blind, placebo-controlled trial. Within the first 48 hours of life, T4 (10 or 20 μg/kg; intravenous or through nasogastric tube, respectively) was administered for a total of 21 days. Chronic lung disease, the primary outcome variable, was defined by oxygen dependency at 28 days of life.

RESULTS: The incidence of chronic lung disease, death, grade III or IV intraventicular hemorrhage, periventicular leukomalacia, and sepsis was not different in the placebo and treated groups.

CONCLUSION: Early T4 supplementation in preterm newborns less than 32 weeks' gestation does not decrease the incidence of chronic lung disease or other complications of prematurity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of California, Los Angeles School of Medicine, Harbor-UCLA Medical Center, Torrance, 90502, CA

    Lynne M Smith, Rosemary D Leake, Nancy Berman, Sylvia Villanueva & Jo Anne Brasel

Authors
  1. Lynne M Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosemary D Leake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nancy Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sylvia Villanueva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jo Anne Brasel
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported in part by grant # 3 M0I RR00425 from the National Institutes of Health, General Clinical Research Center Branch, a Clinical Associate Physician grant awarded to LMS, and a grant from Boots Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, L., Leake, R., Berman, N. et al. Postnatal Thyroxine Supplementation in Infants Less Than 32 Weeks' Gestation: Effects on Pulmonary Morbidity. J Perinatol 20, 427–431 (2000). https://doi.org/10.1038/sj.jp.7200417

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7200417

This article is cited by

Search

Advanced search

Quick links